EPDS: Edinburgh Postnatal Depression Scale
The EPDS is a validated 10-item self-report tool for screening postnatal and perinatal depression. Get instant scoring with severity levels, clinical interpretation, and downloadable results.
Understanding the EPDS: Screening for Postnatal Depression
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire developed by Cox, Holden, and Sagovsky (1987) to screen for postnatal depression in community settings. It is the most widely used screening tool for perinatal mood disorders worldwide and has been translated into over 60 languages.
Why the EPDS matters: Postnatal depression affects approximately 10-15% of new mothers and up to 10% of new fathers in the postpartum period. Left untreated, it can impair parent-infant bonding, child development, and family functioning. Many parents experiencing postnatal depression do not seek help due to stigma, lack of awareness, or difficulty distinguishing depression from normal postpartum adjustment. The EPDS provides a quick, validated way to identify symptoms that warrant professional evaluation.
What the EPDS measures: Unlike general depression scales, the EPDS was specifically designed for the perinatal period. It deliberately excludes somatic symptoms common in normal postpartum recovery (such as fatigue, appetite changes, and sleep disruption from infant care) that would inflate scores on general measures like the PHQ-9 or BDI. The 10 items focus on:
- Anhedonia: Inability to laugh, enjoy things, or look forward to activities (items 1-2)
- Self-blame: Unnecessary guilt and self-criticism (item 3)
- Anxiety and worry: Anxious or panicky feelings without cause (items 4-5)
- Coping difficulty: Feeling overwhelmed and unable to cope (item 6)
- Sleep disturbance due to unhappiness: Difficulty sleeping from emotional distress, not infant care (item 7)
- Sadness and crying: Persistent feelings of misery and tearfulness (items 8-9)
- Self-harm ideation: Thoughts of harming oneself (item 10)
Validation and reliability: The EPDS demonstrates good psychometric properties with sensitivity of 68-86% and specificity of 78-96% for detecting major depression at various cutoff points. Internal consistency is strong (Cronbach's alpha = 0.82-0.87). The original validation study recommended a cutoff of 13 or above for probable depression and 10-12 for possible depression warranting follow-up.
Clinical applications: The EPDS is recommended by NICE, ACOG, and numerous international guidelines for routine postnatal screening. It can be administered during pregnancy (antenatally) and in the postpartum period. Many practices administer it at the 6-week postnatal check, though earlier screening can facilitate prompt intervention. It is also increasingly used to screen fathers and non-birthing partners.
Important disclaimer: The EPDS is a screening tool — it cannot diagnose postnatal depression. A high score should be followed by comprehensive clinical evaluation including psychiatric history, current stressors, social support, and risk assessment. Item 10 (self-harm) should always be reviewed individually regardless of total score. If you or someone you know is in crisis, contact the 988 Suicide & Crisis Lifeline or the Postpartum Support International Helpline at 1-800-944-4773 immediately.
Reference: This assessment is based on the original EPDS by Cox, J.L., Holden, J.M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782-786. The scale is freely available for clinical and research use.
Ready to Begin?
This assessment takes about 3-5 min to complete. Your responses are private, never stored, and you can instantly download your results as a PDF.
How to Take the EPDS Assessment
Answer Questions
Complete the assessment honestly based on how you've been feeling
Get Your Score
Instant calculation using clinically validated scoring methods
Download PDF
Save or share your detailed results with your provider
You'll answer 10 questions about how you have felt during the past 7 days, not just how you feel today. Each response is scored from 0 to 3, producing a total score between 0 and 30.
Before you begin: Please select the answer that comes closest to how you have felt in the past 7 days. Do not take too long over your responses — your first reaction to each statement is the most useful.
The 10 areas assessed include:
Emotional Well-Being:
- Ability to laugh and see the funny side of things
- Looking forward with enjoyment to things
- Feeling sad or miserable
- Being so unhappy that you have been crying
Anxiety and Panic:
- Anxious or worried feelings without good reason
- Feeling scared or panicky without good reason
Coping and Self-Perception:
- Blaming yourself unnecessarily
- Feeling overwhelmed and unable to cope
- Difficulty sleeping due to unhappiness (not baby care)
Safety:
- Thoughts of self-harm
Important notes:
- Items are scored 0-3, with some items reverse-scored so that higher scores always indicate greater symptom severity
- The scale was designed to be completed independently, though a clinician may review responses afterward
- The EPDS can be used during pregnancy and in the postpartum period
Most people complete the assessment in 3-5 minutes.
EPDS Scoring and Clinical Interpretation
Total Score Interpretation (0-30):
0-8 (Low likelihood of depression): Scores in this range suggest postnatal depression is unlikely. Normal postpartum adjustment and everyday stress may still be present. Reassessment is recommended if symptoms emerge or worsen.
9-11 (Possible depression): Scores in this range indicate some depressive symptoms are present. Repeat screening in 2-4 weeks is recommended. Consider offering psychoeducation about postnatal depression and available support resources. A clinical interview may be beneficial.
12-13 (Fairly high possibility of depression): Scores at or above 12 suggest a high likelihood of depression. A comprehensive clinical assessment is strongly recommended, including evaluation of symptom duration, functional impact, and psychosocial stressors. Evidence-based interventions such as CBT, interpersonal therapy, or antidepressant medication should be considered.
14-30 (Probable depression — high severity): Scores in this range indicate significant depressive symptom burden requiring prompt professional attention. Immediate clinical evaluation and treatment planning are warranted. Safety assessment is essential, particularly if item 10 is endorsed.
Critical item — Question 10 (Self-harm):
Any score above 0 on item 10 requires immediate follow-up, regardless of total score. A response of "Sometimes" (2) or "Yes, quite often" (3) warrants urgent safety assessment and may require immediate referral to crisis services.
Cutoff recommendations by setting:
- Community screening: A cutoff of 10 or above maximizes sensitivity for detecting cases that would benefit from further evaluation
- Clinical diagnosis support: A cutoff of 13 or above provides better specificity for probable major depression
- Research: The optimal cutoff depends on the study's purpose and the balance between sensitivity and specificity needed
Monitoring over time: Serial EPDS administration (e.g., every 2-4 weeks) can track symptom trajectory. A decrease of 4 or more points is generally considered clinically meaningful improvement. Scores should be interpreted alongside clinical observation and patient self-report.
Crisis support: If you're experiencing thoughts of self-harm or harming your baby, please call the 988 Suicide & Crisis Lifeline, the Postpartum Support International Helpline at 1-800-944-4773 (call or text), or go to your nearest emergency room immediately.
Frequently Asked Questions
Common questions about the EPDS assessment.
- The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire developed in 1987 by John Cox, Jeni Holden, and Ruth Sagovsky at health centers in Edinburgh and Livingston, Scotland. It was specifically designed to detect postnatal depression in community settings, avoiding somatic symptoms (fatigue, appetite changes, sleep disruption) that overlap with normal postpartum experiences. The EPDS has become the most widely used screening tool for perinatal depression worldwide, translated into over 60 languages, and is recommended by major clinical guidelines including NICE, ACOG, and the WHO.
- The original validation study recommended a cutoff of **13 or above** for probable major depression (sensitivity 86%, specificity 78%). A score of **10-12** indicates possible depression warranting follow-up. However, optimal cutoffs may vary by population, cultural setting, and clinical purpose. Some guidelines recommend screening at **10 or above** to maximize detection sensitivity. Regardless of total score, any endorsement of item 10 (self-harm thoughts) requires immediate clinical follow-up.
- Yes. Although originally developed for postnatal use, the EPDS has been validated for use during pregnancy (antenatal screening) with similar psychometric properties. Antenatal depression affects 10-20% of pregnant women and is a strong predictor of postnatal depression. Many clinical guidelines now recommend screening at least once during pregnancy and again in the postpartum period. The same cutoff scores generally apply, though some studies suggest slightly different optimal cutoffs for antenatal populations.
- Yes. Research has validated the EPDS for use with new fathers and non-birthing partners, though with slightly different cutoff recommendations. Paternal postnatal depression affects approximately 8-10% of new fathers. Studies suggest a cutoff of **10 or above** may be appropriate for fathers (vs. 13 for mothers). The EPDS can be a valuable tool for identifying depression in all new parents, helping ensure the entire family receives support.
- The key difference is that the EPDS was specifically designed for the perinatal period and deliberately **excludes somatic symptoms** (fatigue, sleep changes, appetite changes) that are normal in pregnancy and postpartum. The PHQ-9 includes these somatic items, which can inflate scores in perinatal populations and lead to false positives. The EPDS also asks about the past 7 days (vs. 2 weeks for PHQ-9), captures anxiety symptoms alongside depression, and uses a simpler scoring format. For perinatal screening, the EPDS is generally preferred; the PHQ-9 may be more appropriate for general depression screening.
- Yes. After completing the assessment, you can download your results as a professional PDF report that includes your total score, severity level, clinical interpretation, and your responses to each question. The PDF can be shared with your midwife, health visitor, GP, obstetrician, or therapist, or kept for your personal records to track changes over time.
- Yes. All assessment data is processed entirely in your browser — no information is transmitted to or stored on our servers. Your responses remain completely private, ensuring full privacy and HIPAA compliance for clinical use. You can safely use this tool in healthcare settings.
- Clinical guidelines typically recommend EPDS screening at least once during pregnancy and at the 6-week postnatal visit. For ongoing monitoring, the EPDS can be repeated every 2-4 weeks. Since it asks about the past 7 days, it can be administered more frequently than instruments with longer recall windows. If you're receiving treatment for postnatal depression, regular screening helps track your progress and guides treatment decisions.
- A high score on the EPDS means you should speak with a healthcare professional — your GP, midwife, health visitor, or obstetrician — as soon as possible. A high score does not mean something is wrong with you as a parent; postnatal depression is a common medical condition that responds well to treatment. Options include talking therapies (CBT, interpersonal therapy), support groups, and medication when appropriate. If you have thoughts of harming yourself or your baby, please contact the **988 Suicide & Crisis Lifeline** or the **Postpartum Support International Helpline (1-800-944-4773)** immediately.
Stay Updated on Mental Health Resources
Get notified when we add new assessments, research insights, and mental health resources.